FemTech: Gameto Secures $44M to Advance Stem Cell Therapy for Infertility and Menopause
What You Should Know:
– Gameto, a clinical-stage biotechnology company focused on reproductive health secures $44M in Series C funding, bringing its total capital raised to a leading $127M.
– The funding, led by Overwater Ventures…
Continue Reading